In liposarcoma cells, it results in increased levels of sterol regulatory element binding protein-1 (SREBP-1) and activating transcription factor 6 (ATF6), inhibiting the enzyme site-2-protease (S2P). This evidence concerns the gene SREBF1 and liposarcoma.